"I am simply saying that the current stock price is accurate and that it assumes positive FDA news (therefore, negative FDA news would drop the stock sharply). I am not speaking of future revenues."
You have portrayed the perfect lose-lose scenario. Bad news and we drop sharply, and good news we remain unchanged. If you are shorting the stock, then I hope you get burned badly, and if you really are a shareholder, then I suggest that you sell and move on. There isn't any upside to this stock with your deeply flawed logic.
"earthy, I wish I could agree... either it's a misprint, or they have something they think they know....... shorts don't just massively short in order to scare people..... they don't make a living by bluffing.....something's goin on.."
Another one of your great conspiracy theories? Everybody always knows something you don't? If you don't know what you are invested in, or you don't have any conviction in it, then perhaps you should sell. This stock is worth more than $6.50 regardless of the FDA or anything they might do in the short term with Amniofix.
I'd sure like to see some higher volume and a real good short squeeze. We should get some good traction with annual revenues above 100 million and positive earnings per share.
Selling Osiris is the first thing you have said on this message board that makes good sense.
"- the secondary and the 5x over subscribed was not real and everyone on the street knows it "
and your source for this information that "everyone" knows is Suraj? At this point in time, the secondary doesn't matter anymore. It was a long time ago, and totally irrelevant to today.
Pete said in the last 60 days that he was comfortable with analysts 2015 forecasts of 165 million, but he thought they were conservative. It would follow that 2016 revenues of 200 million would also be too conservative.
The chubby girl from Smutsweeper made such a big deal over Pete's trial, and now the short interest has grown by another 4 million shares after he is vindicated. This reminds me of high stakes poker. The shorts are raising their bet and bluffing with a bad hand.
"hear you #$%$, but this company seems to be more of the "slow leak of good news" comportment...... they're in the "get mileage out of each and every positive release"... "
Pleasing shareholders is a no win game. I own stock in other companies that don't release enough information, and they don't try to defend their stock from short attacks either. I applaud management here for refuting the blatantly false Seeking Alpha articles. I'm sure management had other things to do in their business day, but they took the time to protect my investment here.
This won't stop hedge funds from shorting though. There weren't any large shareholders who ever thought Richard Pearson, or the chubby girl from Smutsweeper had any credibility.
I think Yellen went too far in her comments. She is certainly entitled to her opinions, but in her position of power, she should have kept her opinions to herself. I remain optimistic that we will be much higher after the annual shareholder meeting and the next conference call.
I will presume a transition letter is exactly that. Why would you call it a transition letter otherwise? The stock is down 20% year to date from December 31, yet the company continues to announce positive news. This stock will be above $8.80 in the not too distant future.
"earth, remember the summary by Miss national Enquierer?"
Of course I remember it, and it was a totally insulting and untrue article. Even worse was the photo of the chubby, young author pictured with Jim Cramer. That girl is just plain ugly.
You need to discern between indisputable facts and your opinion. There is a big difference. The credible analysts covering this company don't share your opinion about the valuation either.
"endless monetary ease everywhere.....punish production, reward sloth......I do need a brain wrap.....sorry, don't mean to diverge political....."
You sit in front of a computer screen all day watching every tick of this stock, and you find sloth to be offensive?
"If MDXG hits the 2015 revenue projections, stock should be $9-10 per share by end of 2015. Company gets sold in 2016 or 2017."
I've got a few questions for you. When has management released any 2015 revenue projections? I only heard them say that the analysts projections were conservative.
The stock was close to $9 at the end of 2013 when revenues were around 60 million. Are you suggesting that two years later, after the revenues have tripled, the stock will be, or should be virtually unchanged?
If you think the current share price is "accurate" at $6, then I sure hope you sold quite a bit at the end of 2013 for $8.75 or more.
I happen to think the stock is worth $10 right now, and $15 by next spring. I won't call my opinion an indisputable fact though.
"there are other companies out there developing products to compete all the time, sometimes hedge funds, with millions of dollars in research budgets, are doing research well beyond that available to individual investors.... one cannot sit back idly and complacently while the short interest doubles in a short time frame...."
I've owned this stock for almost 5 years. I've listened to every single conference call, read every press release this company has issued, and read everything written by the analysts. There are 13 million shares short. Big deal. There are 87 million shares long. Some people think it is going up, and others think it is going down. That is what makes a market. The shorts bet big that Pete was going to be barred from holding public office, and Amniofix would be pulled from the market. It looks like the shorts guessed wrong, but that is what makes a market. Let me add one final comment and one final thought for you. If the shorts are relying on information from Suraj, then they are really screwed because that guy is not the brightest bulb on the tree.
You can bet he will be on the next conference call asking his same stupid questions multiple times though. You would think if he wanted clarification on the Medtronic distribution agreement that he would pick up the telephone and ask Pete or Bill.
I don't suspect, or hope that an offer comes this early. Just my opinion, but we don't start attracting serious interest or offers before we reach $12.